Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net income	$ 7,956	$ 22,646
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	15,242	13,919
Amortization	25,968	18,389
Stock-based compensation	6,505	5,561
Deferred income taxes	(3,977)	4,159
Gain on sale of facility	(1,890)	0
Loss on early extinguishment of debt	254	0
Increase (decrease) in cash flows from changes in assets and liabilities, net of acquired assets:
Accounts receivable	11,335	310
Inventories	(22,141)	(25,129)
Accounts payable	(3,420)	7,992
Accrued compensation and benefits	(3,702)	(7,040)
Other assets	(3,042)	2,431
Other liabilities	(4,449)	(4,518)
Total operating	16,683	16,074
Net cash provided by operating activities	24,639	38,720
Cash flows from investing activities:
Purchases of property, plant and equipment	(10,436)	(11,478)
Proceeds from sale of a facility	5,178	0
Payments related to business acquisitions, net of cash acquired	(256,450)	(6,104)
Net cash used in investing activities	(261,708)	(17,582)
Cash flows from financing activities:
Payments on term loan	(6,564)	0
Proceeds from term loan	175,000	0
Proceeds from revolving line of credit, net	61,654	21,000
Payments related to distribution agreement	(16,667)	(16,667)
Payments related to contingent consideration	(200)	(2,423)
Payments related to debt issuance costs	(5,556)	(1,410)
Dividends paid on common stock	(16,649)	(16,565)
Other, net	400	810
Net cash provided by (used in) financing activities	191,418	(15,255)
Effect of exchange rate changes on cash and cash equivalents	95	(6,889)
Net decrease in cash and cash equivalents	(45,556)	(1,006)
Cash and cash equivalents at beginning of period	72,504	66,332
Cash and cash equivalents at end of period	26,948	65,326
Non-cash financing activities:
Dividends payable	$ 5,561	$ 5,540